Volume 15, Number 10—October 2009
Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy
|Rheumatoid arthritis (n = 73)||51||17||5|
|Ankylosing spondylitis (n = 5)||1||3||1|
|Psoriasis (n = 4)||2||2||0|
|Crohn disease (n = 8)||8||0||0|
|Other (n = 15)†||11||3||1|
*TNF-α, tumor necrosis factor-α; NTM, nontuberculous mycobacteria.
†Includes Wegener granulomatosis (n = 2), dermatomyositis (n = 1), uveitis (n = 1), juvenile rheumatoid arthritis (n = 1), and not reported (n = 10).
Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.